{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:24:42Z","timestamp":1792103082692,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370147"],"award-info":[{"award-number":["81370147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10753-022-01653-w","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T22:02:37Z","timestamp":1646517757000},"page":"1692-1699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pre-exposure to Aerosolized Polyvalent Bacterial Lysates Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3808-1195","authenticated-orcid":false,"given":"Xiaoling","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-7659","authenticated-orcid":false,"given":"Shan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-3546","authenticated-orcid":false,"given":"Xiaofang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-733X","authenticated-orcid":false,"given":"Xiaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8331-3584","authenticated-orcid":false,"given":"Jinnong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"1653_CR1","doi-asserted-by":"publisher","unstructured":"Raghu, G., M. Remy-Jardin, J.L. Myers, L. Richeldi, C.J. Ryerson, D.J. Lederer, J. Behr, V. Cottin, S.K. Danoff, F. Morell, K.R. Flaherty, A. Wells, F.J. Martinez, A. Azuma, T.J. Bice, D. Bouros, K.K. Brown, H.R. Collard, A. Duggal, L. Galvin, Y. Inoue, R.G. Jenkins, T. Johkoh, E.A. Kazerooni, M. Kitaichi, S.L. Knight, G. Mansour, A.G. Nicholson, S.N.J. Pipavath, I. Buend\u00eda-Rold\u00e1n, M. Selman, W.D. Travis, S. Walsh, and K.C. Wilson. 2018. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. American Journal of Rspiratory and Citical Care Medicine 198 (5): 44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"1653_CR2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202103-266OC","author":"SA Guler","year":"2021","unstructured":"Guler, S.A., C. Clarenbach, M. Brutsche, K. Hostettler, A.K. Brill, A. Schertel, T.K. Geiser, and M. Funke-Chambour. 2021. Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Cross-over Trial. Annals of the American Thoracic Society. https:\/\/doi.org\/10.1513\/AnnalsATS.202103-266OC.","journal-title":"Annals of the American Thoracic Society"},{"key":"1653_CR3","doi-asserted-by":"publisher","unstructured":"Raghu, G. 2017. Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years. European Respiratory Journal 50 (4). https:\/\/doi.org\/10.1183\/13993003.01209-2017.","DOI":"10.1183\/13993003.01209-2017"},{"issue":"21","key":"1653_CR4","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"G Raghu","year":"2012","unstructured":"Raghu, G., K.J. Anstrom, T.E. King Jr., J.A. Lasky, and F.J. Martinez. 2012. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. New England Journal of Medicine 366 (21): 1968\u20131977. https:\/\/doi.org\/10.1056\/NEJMoa1113354.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"1653_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00063198-200109000-00009","volume":"7","author":"JP Lynch 3rd","year":"2001","unstructured":"Lynch, J.P., 3rd., E. White, and K. Flaherty. 2001. Corticosteroids in idiopathic pulmonary fibrosis. Current Opinion in Pulmonary Medicine 7 (5): 298\u2013308. https:\/\/doi.org\/10.1097\/00063198-200109000-00009.","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"4","key":"1653_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/s0002-9343(00)00711-7","volume":"110","author":"KR Flaherty","year":"2001","unstructured":"Flaherty, K.R., G.B. Toews, J.P. Lynch 3rd., E.A. Kazerooni, B.H. Gross, R.L. Strawderman, K. Hariharan, A. Flint, and F.J. Martinez. 2001. Steroids in idiopathic pulmonary fibrosis: A prospective assessment of adverse reactions, response to therapy, and survival. American Journal of Medicine 110 (4): 278\u2013282. https:\/\/doi.org\/10.1016\/s0002-9343(00)00711-7.","journal-title":"American Journal of Medicine"},{"issue":"2","key":"1653_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.imlet.2014.12.004","volume":"163","author":"IC Papanikolaou","year":"2015","unstructured":"Papanikolaou, I.C., K.A. Boki, E.J. Giamarellos-Bourboulis, A. Kotsaki, K. Kagouridis, N. Karagiannidis, and V.S. Polychronopoulos. 2015. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases. Immunology Letters 163 (2): 179\u2013186. https:\/\/doi.org\/10.1016\/j.imlet.2014.12.004.","journal-title":"Immunology Letters"},{"issue":"5","key":"1653_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00011-015-0816-y","volume":"64","author":"S Li","year":"2015","unstructured":"Li, S., X. Hu, Z. Wang, M. Wu, and J. Zhang. 2015. Different profiles of notch signaling in cigarette smoke-induced pulmonary emphysema and bleomycin-induced pulmonary fibrosis. Inflammation Research 64 (5): 363\u2013371. https:\/\/doi.org\/10.1007\/s00011-015-0816-y.","journal-title":"Inflammation Research"},{"issue":"22","key":"1653_CR9","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","volume":"370","author":"FJ Martinez","year":"2014","unstructured":"Martinez, F.J., J.A. de Andrade, K.J. Anstrom, T.E. King Jr., and G. Raghu. 2014. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. New England Journal of Medicine 370 (22): 2093\u20132101. https:\/\/doi.org\/10.1056\/NEJMoa1401739.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"1653_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/mcp.0000000000000085","volume":"20","author":"AU Wells","year":"2014","unstructured":"Wells, A.U., M. Kokosi, and K. Karagiannis. 2014. Treatment strategies for idiopathic interstitial pneumonias. Current Opinion in Pulmonary Medicine 20 (5): 442\u2013448. https:\/\/doi.org\/10.1097\/mcp.0000000000000085.","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"22","key":"1653_CR11","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L., R.M. du Bois, G. Raghu, A. Azuma, K.K. Brown, U. Costabel, V. Cottin, K.R. Flaherty, D.M. Hansell, Y. Inoue, D.S. Kim, M. Kolb, A.G. Nicholson, P.W. Noble, M. Selman, H. Taniguchi, M. Brun, F. Le Maulf, M. Girard, S. Stowasser, R. Schlenker-Herceg, B. Disse, and H.R. Collard. 2014. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. New England Journal of Medicine 370 (22): 2071\u20132082. https:\/\/doi.org\/10.1056\/NEJMoa1402584.","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"1653_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King, T.E., Jr., W.Z. Bradford, S. Castro-Bernardini, E.A. Fagan, I. Glaspole, M.K. Glassberg, E. Gorina, P.M. Hopkins, D. Kardatzke, L. Lancaster, D.J. Lederer, S.D. Nathan, C.A. Pereira, S.A. Sahn, R. Sussman, J.J. Swigris, and P.W. Noble. 2014. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. New England Journal of Medicine 370 (22): 2083\u20132092. https:\/\/doi.org\/10.1056\/NEJMoa1402582.","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"1653_CR13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMp1500526","volume":"372","author":"BA Karimi-Shah","year":"2015","unstructured":"Karimi-Shah, B.A., and B.A. Chowdhury. 2015. Forced vital capacity in idiopathic pulmonary fibrosis\u2013FDA review of pirfenidone and nintedanib. New England Journal of Medicine 372 (13): 1189\u20131191. https:\/\/doi.org\/10.1056\/NEJMp1500526.","journal-title":"New England Journal of Medicine"},{"key":"1653_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.rmed.2016.02.001","volume":"113","author":"L Richeldi","year":"2016","unstructured":"Richeldi, L., V. Cottin, R.M. du Bois, M. Selman, T. Kimura, Z. Bailes, R. Schlenker-Herceg, S. Stowasser, and K.K. Brown. 2016. Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(\u00ae) trials. Respiratory Medicine 113: 74\u201379. https:\/\/doi.org\/10.1016\/j.rmed.2016.02.001.","journal-title":"Respiratory Medicine"},{"issue":"5","key":"1653_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/s2213-2600(20)30554-3","volume":"9","author":"J Behr","year":"2021","unstructured":"Behr, J., A. Prasse, M. Kreuter, J. Johow, K.F. Rabe, F. Bonella, R. Bonnet, C. Grohe, M. Held, H. Wilkens, P. Hammerl, D. Koschel, S. Blaas, H. Wirtz, J.H. Ficker, W. Neumeister, N. Sch\u00f6nfeld, M. Claussen, N. Kneidinger, M. Frankenberger, S. Hummler, N. Kahn, S. Tello, J. Freise, T. Welte, P. Neuser, and A. G\u00fcnther. 2021. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): A double-blind, randomised, placebo-controlled, phase 2b trial. The Lancet Respiratory Medicine 9 (5): 476\u2013486. https:\/\/doi.org\/10.1016\/s2213-2600(20)30554-3.","journal-title":"The Lancet Respiratory Medicine"},{"issue":"5","key":"1653_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.anai.2015.02.008","volume":"114","author":"SC Kearney","year":"2015","unstructured":"Kearney, S.C., M. Dziekiewicz, and W. Feleszko. 2015. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma. Annals of Allergy, Asthma & Immunology 114 (5): 364\u2013369. https:\/\/doi.org\/10.1016\/j.anai.2015.02.008.","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"1","key":"1653_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1165\/rcmb.2008-0260OC","volume":"42","author":"SE Evans","year":"2010","unstructured":"Evans, S.E., B.L. Scott, C.G. Clement, D.T. Larson, D. Kontoyiannis, R.E. Lewis, P.R. Lasala, J. Pawlik, J.W. Peterson, A.K. Chopra, G. Klimpel, G. Bowden, M. H\u00f6\u00f6k, Y. Xu, M.J. Tuvim, and B.F. Dickey. 2010. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. American Journal of Respiratory Cell and Molecular Biology 42 (1): 40\u201350. https:\/\/doi.org\/10.1165\/rcmb.2008-0260OC.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"12","key":"1653_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1164\/rccm.200607-1038OC","volume":"177","author":"CG Clement","year":"2008","unstructured":"Clement, C.G., S.E. Evans, C.M. Evans, D. Hawke, R. Kobayashi, P.R. Reynolds, S.J. Moghaddam, B.L. Scott, E. Melicoff, R. Adachi, B.F. Dickey, and M.J. Tuvim. 2008. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. American Journal of Respiratory and Critical Care Medicine 177 (12): 1322\u20131330. https:\/\/doi.org\/10.1164\/rccm.200607-1038OC.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"1653_CR19","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1378\/chest.119.6.1742","volume":"119","author":"MD Gutierrez-Tarango","year":"2001","unstructured":"Gutierrez-Tarango, M.D., and A. Berber. 2001. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 119 (6): 1742\u20131748. https:\/\/doi.org\/10.1378\/chest.119.6.1742.","journal-title":"Chest"},{"issue":"6","key":"1653_CR20","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1378\/chest.122.6.2042","volume":"122","author":"UB Schaad","year":"2002","unstructured":"Schaad, U.B., R. Mutterlein, H. Goffin, and Group BV-CS. 2002. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: A double-blind, placebo-controlled multicenter study. Chest 122 (6): 2042\u20132049. https:\/\/doi.org\/10.1378\/chest.122.6.2042.","journal-title":"Chest"},{"issue":"1","key":"1653_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000093933","volume":"74","author":"M Soler","year":"2007","unstructured":"Soler, M., R. Mutterlein, G. Cozma, and O.M.S.G. Swiss-German. 2007. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Respiration 74 (1): 26\u201332. https:\/\/doi.org\/10.1159\/000093933.","journal-title":"Respiration"},{"issue":"4","key":"1653_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00408-016-9880-5","volume":"194","author":"AM Koatz","year":"2016","unstructured":"Koatz, A.M., N.A. Coe, A. Ciceran, and A.J. Alter. 2016. Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections. Lung 194 (4): 687\u2013697. https:\/\/doi.org\/10.1007\/s00408-016-9880-5.","journal-title":"Lung"},{"key":"1653_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1183\/09031936.01.00220001","volume":"18","author":"J Boe","year":"2001","unstructured":"Boe, J., J.H. Dennis, B.R. O\u2019Driscoll, T.T. Bauerz, M. Carone, B. Dautzenberg, P. Diot, K. Heslop, and L. Lannefors. 2001. European Respiratory Society Guidelines on the use of nebulizers. European Respiratory Journal 18: 228\u2013242. https:\/\/doi.org\/10.1183\/09031936.01.00220001.","journal-title":"European Respiratory Journal"},{"issue":"3","key":"1653_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., M. Nihal, and N. Ahmad. 2008. Dose translation from animal to human studies revisited. FASEB Journal 22 (3): 659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF.","journal-title":"The FASEB Journal"},{"issue":"10","key":"1653_CR25","first-page":"1269","volume":"239","author":"RS Nolen","year":"2011","unstructured":"Nolen, R.S. 2011. AVMA board approves Panel on Euthanasia report updated guidelines cover more species and methods. Journal of the American Veterinary Medical Association 239 (10): 1269.","journal-title":"Journal of the American Veterinary Medical Association"},{"issue":"4","key":"1653_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.840","volume":"9","author":"XF Zheng","year":"2021","unstructured":"Zheng, X.F., D.D. Chen, X.L. Zhu, J.M. Le Grange, L.Q. Zhou, and J.N. Zhang. 2021. Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation. Pharmacology Research & Perspectives 9 (4): e00840. https:\/\/doi.org\/10.1002\/prp2.840.","journal-title":"Pharmacology Research & Perspectives"},{"key":"1653_CR27","doi-asserted-by":"publisher","unstructured":"H\u00fcbner, R.H., W. Gitter, N.E. El Mokhtari, M. Mathiak, M. Both, H. Bolte, S. Freitag-Wolf, and B. Bewig. 2008. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44 (4): 507\u2013517. https:\/\/doi.org\/10.2144\/000112729.","DOI":"10.2144\/000112729"},{"key":"1653_CR28","doi-asserted-by":"crossref","unstructured":"Bigatto, V., E. Manni, D. Pompilio, M. Brana\u2019, and F. Andreetta. 2019. Quantitation of hydroxyproline in a mouse model of bleomycin-induced lung fibrosis: comparison with histological analysis.  ERS International Congress 2019 abstracts.","DOI":"10.1183\/13993003.congress-2019.PA2419"},{"issue":"2","key":"1653_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/9780470942390.mo110201","volume":"2","author":"F Daubeuf","year":"2012","unstructured":"Daubeuf, F., and N. Frossard. 2012. Performing Bronchoalveolar Lavage in the Mouse. Current Protocols in Mouse Biology 2 (2): 167\u2013175. https:\/\/doi.org\/10.1002\/9780470942390.mo110201.","journal-title":"Curr Protoc Mouse Biol"},{"issue":"2","key":"1653_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2500\/ajra.2013.27.4021","volume":"28","author":"L Han","year":"2014","unstructured":"Han, L., C.P. Zheng, Y.Q. Sun, G. Xu, W. Wen, and Q.L. Fu. 2014. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. American Journal of Rhinology & Allergy 28 (2): 110\u2013116. https:\/\/doi.org\/10.2500\/ajra.2013.27.4021.","journal-title":"American Journal of Rhinology & Allergy"},{"issue":"6","key":"1653_CR31","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/iai.69.6.3719-3727.2001","volume":"69","author":"LM Bowman","year":"2001","unstructured":"Bowman, L.M., and P.G. Holt. 2001. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infection and Immunity 69 (6): 3719\u20133727. https:\/\/doi.org\/10.1128\/iai.69.6.3719-3727.2001.","journal-title":"Infection and Immunity"},{"key":"1653_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","volume":"1627","author":"T Liu","year":"2017","unstructured":"Liu, T., F.G. De Los Santos, and S.H. Phan. 2017. The Bleomycin Model of Pulmonary Fibrosis. Methods in Molecular Biology 1627: 27\u201342. https:\/\/doi.org\/10.1007\/978-1-4939-7113-8_2.","journal-title":"Methods in Molecular Biology"},{"key":"1653_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels, P., C.C. Moor, J.H. von der Th\u00fcsen, M.S. Wijsenbeek, and M. Kool. 2019. Inflammation and immunity in IPF pathogenesis and treatment. Respiratory Medicine 147: 79\u201391. https:\/\/doi.org\/10.1016\/j.rmed.2018.12.015.","journal-title":"Respiratory Medicine"},{"issue":"1","key":"1653_CR34","first-page":"37","volume":"32","author":"SD Skaria","year":"2015","unstructured":"Skaria, S.D., J. Yang, R. Condos, and G.C. Smaldone. 2015. Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF). Sarcoidosis Vasculitis and Diffuse Lung Diseases 32 (1): 37\u201342.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1653_CR35","doi-asserted-by":"publisher","unstructured":"Wang, J., M. Lesko, M.H. Badri, B.C. Kapoor, B.G. Wu, Y. Li, G.C. Smaldone, R. Bonneau, Z.D. Kurtz, R. Condos, and L.N. Segal. 2017. Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-gamma. ERJ Open Research 3 (3). https:\/\/doi.org\/10.1183\/23120541.00008-2017.","DOI":"10.1183\/23120541.00008-2017"},{"key":"1653_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114356","volume":"183","author":"CJ Chang","year":"2021","unstructured":"Chang, C.J., C.F. Lin, C.H. Lee, H.C. Chuang, F.C. Shih, S.W. Wan, C. Tai, and C.L. Chen. 2021. Overcoming interferon (IFN)-gamma resistance ameliorates transforming growth factor (TGF)-beta-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis. Biochemical Pharmacology 183: 114356. https:\/\/doi.org\/10.1016\/j.bcp.2020.114356.","journal-title":"Biochemical Pharmacology"},{"issue":"9685","key":"1653_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0140-6736(09)60551-1","volume":"374","author":"TE King Jr","year":"2009","unstructured":"King, T.E., Jr, C. Albera, W.Z. Bradford, U. Costabel, P. Hormel, L. Lancaster, P.W. Noble, S.A. Sahn, J. Szwarcberg, M. Thomeer, D. Valeyre, and R.M. du Bois. 2009. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomised, placebo-controlled trial. The Lancet 374 (9685): 222\u2013228. https:\/\/doi.org\/10.1016\/s0140-6736(09)60551-1.","journal-title":"The Lancet"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01653-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:09:14Z","timestamp":1655251754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01653-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01653-w","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"Ethical approval was obtained from the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}